A comparative study of the protein c pathway in septic and nonseptic patients with organ failure

被引:58
作者
Borgel, Delphine
Bornstain, Caroline
Reitsma, Pieter H.
Lerolle, Nicolas
Gandrille, Sophie
Dali-Ali, Fouad
Esmon, Charles T.
Fagon, Jean-Yves
Aiach, Martine
Diehl, Jean-Luc
机构
[1] Hop Europeen Georges Pompidou, AP HP, INSERM, Serv Reanimat Med,U765, F-75908 Paris 15, France
[2] Hop Europeen Georges Pompidou, AP HP, Serv Hematol Biol, Paris, France
[3] Univ Paris 05, Paris, France
[4] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands
[5] Howard Hughes Med Inst, Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK USA
关键词
protein C; organ failure; coagulation; inflammatory profile;
D O I
10.1164/rccm.200611-1692OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Severe sepsis is associated with an exacerbated procoagulant state with protein C (PC) system impairment. In contrast, the inflammatory and coagulation status of nonseptic patients with organ failure (OF) is less documented. Objectives: To compare coagulation activation, focusing on the PC system, and inflammatory status in septic and nonseptic patients with OF. Methods: Thirty patients with severe sepsis and 30 nonseptic patients were recruited at the onset of OF and compared with 30 matched healthy subjects. We performed an extensive analysis of the PC pathway, including plasma protein measurements and quantification of leukocyte expression of PC system receptors. In addition, we analyzed the inflammatory status, based on inflammation-related gene leukocyte expression. Measurements and Main Results: We observed coagulation activation, reflected by a similar increase in tissue factor mRNA expression, in the two patient groups when compared with the healthy subjects. Soluble thrombomodulin levels were higher in septic patients than in healthy control subjects, whereas PC, protein S, and soluble endothelial cell PC receptor levels were lower. Similar results were obtained in nonseptic patients with OF. Monocyte thrombomodulin overexpression, together with increased circulating levels of activated PC, suggests that the capacity for PC activation is at least partly preserved in both settings. No difference in the inflammatory profile was found between septic and nonseptic patients. Conclusions: The pathogenesis of OF in critical care patients is characterized by an overwhelming systemic inflammatory response and by exacerbated coagulation activation, independently of whether or not infection is the triggering event.
引用
收藏
页码:878 / 885
页数:8
相关论文
共 37 条
[1]   Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial [J].
Abraham, E ;
Reinhart, K ;
Opal, S ;
Demeyer, I ;
Doig, C ;
Rodriguez, AL ;
Beale, R ;
Svoboda, P ;
Laterre, PF ;
Simon, S ;
Light, B ;
Spapen, H ;
Stone, J ;
Seibert, A ;
Peckelsen, C ;
De Deyne, C ;
Postier, R ;
Pettilä, V ;
Sprung, CL ;
Artigas, A ;
Percell, SR ;
Shu, V ;
Zwingelstein, C ;
Tobias, J ;
Poole, L ;
Stolzenbach, JC ;
Creasey, AA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02) :238-247
[2]   Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death [J].
Abraham, E ;
Laterre, P ;
Garg, R ;
Levy, H ;
Talwar, D ;
Trzaskoma, BL ;
Francois, B ;
Guy, JS ;
Bruckmann, M ;
Rea-Neto, A ;
Rossaint, R ;
Perrotin, D ;
Sablotzki, A ;
Arkins, N ;
Utterback, BG ;
Macias, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1332-1341
[3]   Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest - Implication of the protein C anticoagulant pathway [J].
Adrie, C ;
Monchi, M ;
Laurent, I ;
Um, S ;
Yan, SB ;
Thuong, M ;
Cariou, A ;
Charpentier, J ;
Dhainaut, JF .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (01) :21-28
[4]   The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome [J].
Aird, WC .
BLOOD, 2003, 101 (10) :3765-3777
[5]   THE COAGULOPATHY OF HEAT-STROKE ALTERATIONS IN COAGULATION AND FIBRINOLYSIS IN HEAT-STROKE PATIENTS DURING THE PILGRIMAGE (HAJJ) TO MAKKAH [J].
ALMASHHADANI, SA ;
GADER, AGMA ;
ALHARTHI, SS ;
KANGAV, D ;
SHAHEEN, FA ;
BOGUS, F .
BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (05) :731-736
[6]   DIURNAL-VARIATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ITS RAPID INHIBITOR (PAI-1) [J].
ANGLETON, P ;
CHANDLER, WL ;
SCHMER, G .
CIRCULATION, 1989, 79 (01) :101-106
[7]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[8]   Elevated plasma procoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease [J].
Ashitani, J ;
Mukae, H ;
Arimura, Y ;
Matsukura, S .
INTERNAL MEDICINE, 2002, 41 (03) :181-185
[9]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[10]   Changes of the hemostatic network in critically ill patients - Is there a difference between sepsis, trauma, and neurosurgery patients? [J].
Boldt, J ;
Papsdorf, M ;
Rothe, A ;
Kumle, B ;
Piper, S .
CRITICAL CARE MEDICINE, 2000, 28 (02) :445-450